Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 9, 2024Leukemia & lymphoma/Leukemia and lymphoma

Stem cell allografting for chronic Myeloid leukemia in the tyrosine kinase era – forgotten but not gone

View Full Paper
Ask AI
Bookmark
Share

Authors

KTKenny TangJLJeffrey H. Lipton

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tang et al. (2024) studied this question.

synapsesocial.com/papers/68e7a413b6db64358770c150https://doi.org/10.1080/10428194.2024.2313626
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia2014 · 164 citations
  2. 2Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]1995 · 1,974 citations
  3. 3Bone Marrow Transplantation for Chronic Myelogenous Leukemia in Chronic Phase1988 · 863 citations
  4. 4Impact of TKIs post–allogeneic hematopoietic cell transplantation in Philadelphia chromosome–positive ALL2020 · 73 citations
  5. 5Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT2005 · 174 citations